Brazil Preclinical Cro Market Size & Outlook, 2023-2030
Brazil preclinical cro market, 2018-2030 (US$M)
Related Markets
Brazil preclinical cro market highlights
- The Brazil preclinical cro market generated a revenue of USD 82.5 million in 2023 and is expected to reach USD 136.5 million by 2030.
- The Brazil market is expected to grow at a CAGR of 7.4% from 2024 to 2030.
- In terms of segment, toxicology testing was the largest revenue generating service in 2023.
- Bioanalysis and DMPK studies is the most lucrative service segment registering the fastest growth during the forecast period.
Preclinical cro market data book summary
| Market revenue in 2023 | USD 82.5 million |
| Market revenue in 2030 | USD 136.5 million |
| Growth rate | 7.4% (CAGR from 2023 to 2030) |
| Largest segment | Toxicology testing |
| Fastest growing segment | Bioanalysis and DMPK studies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bioanalysis and DMPK studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology |
| Key market players worldwide | Eurofins Scientific SE, Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Intertek Group PLC, Labcorp Holdings Inc, Crown Bioscience, SGA |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.4% of the global preclinical cro market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil preclinical cro market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 136.5 million by 2030.
Toxicology testing was the largest segment with a revenue share of 22.55% in 2023. Horizon Databook has segmented the Brazil preclinical cro market based on bioanalysis and dmpk studies, toxicology testing, compound management, chemistry, safety pharmacology covering the revenue growth of each sub-segment from 2018 to 2030.
Brazil holds a major share of the preclinical trials outsourcing market in Latin America and is expected to maintain its dominance over the forecast period. Among the Latin American countries, the majority of preclinical trials are conducted in Brazil owing to its cost-effectiveness and diverse population. With a large number of trials conducted in this region, market growth is expected to propel country growth.
The country has witnessed substantial demand from the biotechnology and healthcare industries within the market. Increasing R&D capabilities in Brazil, and government initiatives to collaborate with global companies are likely to attract investments from pharmaceutical and biotech companies. This is expected to boost market growth during the forecast period.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Preclinical CRO Market Scope
Preclinical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil preclinical cro market size, by service, 2018-2030 (US$M)
Brazil Preclinical CRO Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
